HSA Shop logoHSA Shop

HSA Guide

Is Pepto-Bismol HSA Eligible?

Published March 29, 2024

Check eligibility on the gobrowse 7,000+ HSA-eligible products in the free app.

Get the app
Short answer: Pepto-Bismol is generally not HSA eligible unless prescribed by a doctor or included in a prescribed treatment plan, and you should check your HSA provider or IRS guidelines.

General HSA ineligibility for Pepto-Bismol

Pepto-Bismol is a commonly used medication for stomach issues such as indigestion, heartburn, nausea, and diarrhea. If you're wondering whether Pepto-Bismol is HSA eligible, the answer is generally no.

Health Savings Accounts (HSAs) are designed to cover qualified medical expenses, and over-the-counter medications like Pepto-Bismol are typically not eligible unless prescribed by a doctor.

When Pepto-Bismol may qualify

However, there are exceptions where Pepto-Bismol may be considered HSA eligible:

  • If you have a prescription from a doctor for Pepto-Bismol, you can use your HSA funds to purchase it.
  • If Pepto-Bismol is part of a medical treatment plan prescribed by a healthcare provider, it may be deemed eligible.
  • Some HSA providers may have their own specific guidelines regarding the eligibility of over-the-counter medications.

It's always best to check with your HSA provider or refer to the IRS guidelines to determine if Pepto-Bismol or any other over-the-counter medication is HSA eligible. Keeping track of your medical expenses and ensuring compliance with HSA rules will help you make the most of your account.

While Pepto-Bismol is a popular remedy for various digestive discomforts including nausea and diarrhea, most people may not realize that it is typically not eligible for purchase with Health Savings Account (HSA) funds. That said, if you've received a prescription from your doctor, you can apply HSA funds towards this over-the-counter medication.

Free App

Browse 7,000+ HSA-Eligible Products

Search by symptom, get price alerts, and build your HSA shopping list — all in the free app.

← Back to all articles